+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Retinal Vein Occlusion"

From
From
Ophthalmic Photocoagulator - Global Strategic Business Report - Product Thumbnail Image

Ophthalmic Photocoagulator - Global Strategic Business Report

  • Report
  • November 2026
  • 384 Pages
  • Global
From
From
Vitreous Tamponades - Global Strategic Business Report 2026 - Product Thumbnail Image

Vitreous Tamponades - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 174 Pages
  • Global
From
From
From
From
From
Ophthalmoscope Market Outlook: Global Strategic Report 2026-2031 - Product Thumbnail Image

Ophthalmoscope Market Outlook: Global Strategic Report 2026-2031

  • Report
  • September 2026
  • 101 Pages
  • Global
From
Ophthalmic Optical Coherence Tomography Market Analysis - Product Thumbnail Image

Ophthalmic Optical Coherence Tomography Market Analysis

  • Report
  • September 2026
  • 139 Pages
  • Global
From
Saudi Arabia Vision Care Market - Services & Forecast 2026-2034 - Product Thumbnail Image

Saudi Arabia Vision Care Market - Services & Forecast 2026-2034

  • Report
  • September 2026
  • 200 Pages
  • Saudi Arabia
From
From
From
Loading Indicator

Retinal Vein Occlusion (RVO) is a condition in which the veins in the retina become blocked, leading to vision loss. It is the second most common cause of vision loss in the elderly, and is often caused by hypertension, diabetes, and other vascular diseases. Treatment for RVO includes laser photocoagulation, intravitreal injections, and vitrectomy. Optical treatments such as optical coherence tomography (OCT) and fundus photography are used to diagnose and monitor the condition. In the RVO market, companies such as Carl Zeiss Meditec, Topcon Corporation, Heidelberg Engineering, Optovue, and Nidek Co. Ltd. are involved in the development and manufacture of optical imaging systems and treatments for RVO. These companies provide a range of products and services, including OCT systems, fundus cameras, laser photocoagulation systems, and intravitreal injections. Show Less Read more